Vitamin C as cancer therapy: An overview

Journal of Orthomolecular Medicine

Volumn 15, Issue 4, 2000, Pages 175-180

  Hoffer, L J ^a   Tamayo, C ^b   Richardson, M A ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CYTOTOXIC AGENT; INTERLEUKIN 2;

CANCER; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RESEARCH; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; HUMAN; NUTRIENT; OUTCOMES RESEARCH; TREATMENT OUTCOME;

EID: 0034507998     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Fisher P, Ward A: Complementary medicine in Europe. BMJ, 1994; 309: 107-111.
2. MacLennan AH, Wilson DH, Taylor AW: Prevalence and cost of alternative medicine in Australia. Lancet, 1996; 347: 569-73.
3. Eisenberg D, Davis R, Ettner S, et al. Trends in Alternative Medicine Use in the United States, 1990-1997 Results of a Follow-up National Survey. JAMA, 1998; 280: 1569-1575.
4. Haskell W, Alles W, Metz RD: Americans mingle complementary techniques with traditional medical services, survey shows September 21, 1998-Stanford. Business Wire Health Wire, 1998.
5. McGinnis LS: Alternative therapies, 1990. An overview. Cancer, 1991; 67: 1788-93.
6. Campion EW: Why unconventional medicine? N Engl J Med, 1993; 328(4): 282-283.
7. Smith T: Alternative Medicine. BMJ, 1983; 287: 307-8.
8. Eisenberg D, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL: Unconventional medicine in the United States: Prevalance, costs, and patterns of use. N Engl J Med, 1993; 328: 246-252.
9. Cassileth BR, Lusk EF, Strouse TB, Bodenheimer BJ: Contemporary unorthodox treatments in cancer medicine: A study of patients, treatments, and practitioners. Ann Intern Med, 1984; 101: 105-112.
10. American Cancer Society. Unproven methods of cancer management - macrobiotic diets for the treatment of cancer. CA: A Cancer Journal for Clinicians, 1989; 39: 248-251.
11. Lerner IJ, Kennedy BJ: The prevalence of questionable methods of cancer treatments in the United States. Cancer, 1992;42:181-191.
12. Ernst E, Cassileth BR: The prevalence of complementary/alternative medicine in cancer. A systematic review. Cancer, 1998; 83: 777-782.
13. National Cancer Institute of Canada. Canadian Cancer Statistics - 1998. Toronto, Canada; 1998.
14. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society, Inc.; 1994.
15. American Cancer Society. Cancer facts & figures-1997. 1997; 97-300M-No. 5008.97.
16. Cole P: Of Light Bulbs and Wine Glasses: Risk Factors and Mortality Trends. In: Maulitz RC, Ed. Unnatural Causes: The Three Leading Killer Diseases in America. New Brunswick, NJ: Rutgers University Press; 1988:83-91.
17. Sondik EJ: Progress in cancer prevention and control. The three leading killer diseases in America. In eds. Maulitz RC: Unnatural Causes: The Three Leading Killer Diseases in America, New Brunswick, NJ: Rutgers University Press; 1988: 111-134.
18. Cole P, Amoateng-Adjepong Y: Cancer Prevention: Accomplishments and Prospects. Am J Public Health, 1994; 34: 8-10.
19. Lerner M: Choices in Healing: Integrating the Best of Conventional and Complementary Approaches to Cancer, Cambridge, MA: MIT Press; 1994.
20. Tannock IF, Warr DG: Unconventional therapies for cancer: a refuge from the rules of evidence? CMAJ, 1998; 159: 801-802.
21. Angell M, Kassirer P: Alternative medicine - the risks of untested and unregulated remedies. N Engl J Med, 1998; 339: 839-841.
22. Halperin EC: Let's abolish the office of alternative medicine of the National Institutes of Health. N Carolina Med J, 1998; 59: 21-23.
23. Stalker DF: Evidence and alternative medicine. The Mount Sinai J Med. 1995; 62: 132-143.
24. Richardson MA, Ramirez T, Nanney K, Singletary SE: Alternative/complementary medicine: implications for patient-provider communication. (Abstract). 35th Annual ASCO Meeting. 1998.
25. Coss RA, McGrath P, Caggiano V. Alternative care: patient choices for adjunct therapies within a cancer center. Cancer Practice, 1998; 6: 176-181.
26. Jacobs JJ: Unproven alternative methods of cancer treatment. In eds. Devita Jr, VT, Hellman, S, Rosenberg, SA: Cancer: Principles and Practices of Oncology, Philadelphia, PA: Lippincott-Raven Publishers; 1997: 2993.
27. Astin JA: Why patients use alternnative medicine. Results of a national study. JAMA, 1998; 279: 1548-1553.
28. Fontanarosa PB: Alternative medicine meets science. JAMA, 1998;280:1618-1619.
29. DiPaola RS, Zhang H, Lambert GH, et al: Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. NEJM, 1998; 339: 785-791.
30. Hoey J: The arrogance of science and the pitfalls of hope. CMAJ, 1998; 159: 803-804.
31. Jonas WB: Alternative Medicine - learning from the past, examining the present, advancing the future. JAMA, 1998;280:1616-1618.
32. Mundy GR, Yoneda T: Bisphosphonates as anticancer drugs. N Engl J Med, 1998; 339: 398-400.
33. Hawkins MJ, Hoth DF, Wittes RE: Clinical development of biological response modifiers: comparison with cytotoxic drugs. Sem Oncol, 1986; 13: 132-40.
34. Witztum JL: To E or not to E - how do we tell? Circulation, 1998; 50: 2785-2787.
35. US Congress OTA. Vitamin C. Washington DC: Reprinted by the U.S. Congress Office of Technology Assessment, 1990.
36. Canadian Breast Cancer Research Initiative. Essiac: An information package. Toronto CBCRI Pamphlet, http://www.Breast.Cancer.Ca/English/e_Frame.Htm. 1996.
37. Parkinson DR: Present status of biological response modifiers in cancer. Am J Med, 1995; 99: 54S-56S.
38. Hoffer LJ: Nutrients as biologic response modifiers. Quillin P, Williams RM, Eds. Adjuvant Nutrition in Cancer Treatment. Arlington Heights, IL: Cancer Treatment Research Foundation; 1993: 55-79.
39. Marcus SL, Petrylak DP, Dutcher JP, et al: Hypovitaminosis C in patients treated with high-dose interleukin-2 and lymphokine-activated killer cells. Am J Clin Nutr, 1991; 54: 1292S-1297S.